BOT 7.25% 32.0¢ botanix pharmaceuticals ltd

Bot Chart, page-7664

  1. 525 Posts.
    lightbulb Created with Sketch. 339
    Annacor had prediction of peak sale of $2bil per annum. Annacor was paid 2.5x their peak sales. obviously patient lengths come in to play, market size and lots of other factors.

    we are predicted to be $950m per annum peak sales going by the euroz report. that is with a 3% market share from the 3.7m patients. doesn't include the broader market that would also use this product.

    articles I have read suggest there can be a lot of variables but often a 10% market share for a best in class is probably not unreasonable and to base your figures off for valuations. So call it $2bil per annum peak sales being conservative which is 6-7% market share. maybe we could get a similar price to Annacor.

    $5.2bil usd = $5.2 a share for us.

    please vinnie I hope you are reading these same articles about about how to value your biotech company
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.025(7.25%)
Mkt cap ! $581.5M
Open High Low Value Volume
35.0¢ 35.0¢ 32.0¢ $1.732M 5.231M

Buyers (Bids)

No. Vol. Price($)
11 413440 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 46819 2
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.